International Bifurcation Study

Launched by MESHALKIN RESEARCH INSTITUTE OF PATHOLOGY OF CIRCULATION · Feb 28, 2018

Keywords

ClinConnect Summary

The International Bifurcation Study (IBS) is a clinical trial that is looking into how well stenting works for patients with coronary bifurcation lesions. A bifurcation lesion is a specific type of blockage in the heart's arteries where one artery splits into two. This study aims to gather information from different medical centers about the procedures used and the outcomes for patients after they receive treatment. By doing this, researchers hope to understand the long-term effects of this treatment and identify any factors that might lead to complications.

To participate in this study, individuals must be at least 18 years old and have a diagnosed bifurcation lesion in one of the major arteries supplying blood to the heart. The study is currently open for recruitment, meaning they are looking for volunteers. If you choose to take part, you will be contributing to important research that could help improve treatment for future patients. It's important to note that if you decide not to participate, you can still receive standard medical care.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age ≥ 18 years
• • Any type of bifurcation lesion in major epicardial artery
• Exclusion Criteria:
• • Patient refused informed consent to participate in the registry